Results 111 to 120 of about 39,225 (199)

Loss of CHTF18-RFC2/5 leads to replicative gaps and sensitivity to PARP inhibitors. [PDF]

open access: yesNAR Cancer
Buckley-Benbow L   +4 more
europepmc   +1 more source

NAD<sup>+</sup>‒circadian rhythm coupling in dementia. [PDF]

open access: yesAlzheimers Dement
Zhang SQ   +7 more
europepmc   +1 more source

In Vitro Evaluation of PARP1 Inhibitor Olaparib-Cyanine Dye Conjugate for the Treatment of Glioblastoma. [PDF]

open access: yesChemMedChem
Dumo C   +8 more
europepmc   +1 more source

SIRT7-mediated deacetylation of XRCC6 at lysine 591 drives breast cancer progression. [PDF]

open access: yesFront Oncol
Yin J   +15 more
europepmc   +1 more source

Lactylome Reprogramming Mediates Therapeutic Response and Adaptation to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma. [PDF]

open access: yesMol Cell Proteomics
Peng P   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy